Leukocyte telomere length in a population-based case-control study of ovarian cancer: A pilot study

Cancer Causes and Control

Volumn 21, Issue 1, 2010, Pages 77-82

  Mirabello, Lisa ^a   Garcia Closas, Montserrat ^a   Cawthon, Richard ^b   Lissowska, Jolanta ^c   Brinton, Louise A ^a   Pepłońska, Beata ^d   Sherman, Mark E ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Case control study; Epidemiology; Ovarian cancer; Telomere length

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE CONTROL STUDY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY CANCER; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES; MIDDLE AGED; OVARIAN NEOPLASMS; PILOT PROJECTS; RISK FACTORS; TELOMERE;

EID: 74149087518     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9436-6     Document Type: Article

References (26)

1. IK Moon MB Jarstfer 2007 The human telomere and its relationship to human disease, therapy, and tissue engineering Front Biosci 12 4595 4620 10.2741/2412 1:CAS:528:DC%2BD2sXms1Klt7w%3D 17485399
2. D Gilley H Tanaka BS Herbert 2005 Telomere dysfunction in aging and cancer Int J Biochem Cell Biol 37 1000 1013 10.1016/j.biocel.2004.09.003 1:CAS:528:DC%2BD2MXhvVCqur8%3D 15743674 (Pubitemid 40311742)
3. RS Maser RA DePinho 2002 Connecting chromosomes, crisis, and cancer Science 297 565 569 10.1126/science.297.5581.565 1:CAS:528:DC%2BD38XlslWkurc%3D 12142527 (Pubitemid 34815334)
4. SA Stewart RA Weinberg 2006 Telomeres: cancer to human aging Annu Rev Cell Dev Biol 22 531 557 10.1146/annurev.cellbio.22.010305.104518 1:CAS:528:DC%2BD28Xht1yjs7jE 16824017 (Pubitemid 44778007)
5. RR Plentz M Caselitz JS Bleck, et al. 2004 Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma Hepatology 40 80 86 10.1002/hep.20271 1:CAS:528:DC%2BD2cXmtlSgtb8%3D 15239089 (Pubitemid 38868926)
6. KL Rudolph M Millard MW Bosenberg RA DePinho 2001 Telomere dysfunction and evolution of intestinal carcinoma in mice and humans Nat Genet 28 155 159 10.1038/88871 1:CAS:528:DC%2BD3MXktFOrtLk%3D 11381263 (Pubitemid 32538061)
7. MA Blasco HW Lee MP Hande, et al. 1997 Telomere shortening and tumor formation by mouse cells lacking telomerase RNA Cell 91 25 34 10.1016/S0092-8674(01)80006-4 1:CAS:528:DyaK2sXmslGgt7w%3D 9335332 (Pubitemid 27431310)
8. J Shen MB Terry I Gurvich, et al. 2007 Short telomere length and breast cancer risk: a study in sister sets Cancer Res 67 5538 5544 10.1158/0008-5472. CAN-06-3490 1:CAS:528:DC%2BD2sXmtVaitbo%3D 17545637 (Pubitemid 46997296)
9. JS Jang YY Choi WK Lee, et al. 2008 Telomere length and the risk of lung cancer Cancer Sci 99 1385 1389 10.1111/j.1349-7006.2008.00831.x 1:CAS:528:DC%2BD1cXot1eit7s%3D 18452563 (Pubitemid 351761728)
10. M McGrath JYY Wong D Michaud DJ Hunter I De Vivo 2007 Telomere length, cigarette smoking, and bladder cancer risk in men and women Cancer Epidemiol Biomarkers Prev 16 815 819 10.1158/1055-9965.EPI-06-0961 1:CAS:528: DC%2BD2sXjvV2ms74%3D 17416776 (Pubitemid 46650587)
11. X Wu CI Amos Y Zhu, et al. 2003 Telomere dysfunction: a potential cancer predisposition factor J Natl Cancer Inst 95 1211 1218 1:CAS:528: DC%2BD3sXntlWqsb4%3D 12928346
12. L Shao CG Wood D Zhang, et al. 2007 Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer J Urol 178 1492 1496 10.1016/j.juro.2007.05.112 17707063 (Pubitemid 47368377)
13. AM Joshua B Vukovic I Braudey, et al. 2007 Telomere attrition in isolated high-grade prostaticintraepithelial neoplasia and surrounding stroma is predictive of prostate cancer Neoplasia 9 81 89 10.1593/neo.06745 1:CAS:528:DC%2BD2sXhvFChtL0%3D 17325746 (Pubitemid 46203936)
14. M Kammori K Takubob K Nakamurab, et al. 2000 Telomerase activity and telomere length in benign and malignant human thyroid tissues Cancer Lett 159 175 181 10.1016/S0304-3835(00)00547-4 1:CAS:528:DC%2BD3cXms1Squ74%3D 10996729
15. T Idei H Sakamoto T Yamamoto 2002 Terminal restriction fragments of telomere are detectable in plasma and their length correlates with clinical status of ovarian cancer patients J Int Med Res 30 244 250 1:CAS:528: DC%2BD38XlvFGkt7w%3D 12166340
16. CM Counter HW Hirte S Bacchetti CB Harley 1994 Telomerase activity in human ovarian carcinoma Proc Natl Acad Sci USA 91 2900 2904 10.1073/pnas.91.8. 2900 1:CAS:528:DyaK2cXivFGntL4%3D 8159676
17. SJ Wang T Sakamoto S Yasuda, et al. 2002 The relationship between telomere length and telomerase activity in gynecologic cancers Gynecol Oncol 84 81 84 10.1006/gyno.2001.6483 1:CAS:528:DC%2BD3MXptFegtb4%3D 11748981 (Pubitemid 34056471)
18. J Murakami N Nagai K Ohama H Tahara T Ide 1997 Telomerase activity in ovarian tumors Cancer 80 1085 1092 10.1002/(SICI)1097-0142(19970915)80: 6<1085::AID-CNCR11>3.0.CO;2-4 1:STN:280:DyaK2svkvFansg%3D%3D 9305709 (Pubitemid 27427608)
19. M García-Closas L Brinton J Lissowska, et al. 2007 Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study BMC Cancer 7 60 10.1186/1471-2407-7-60 17411440 (Pubitemid 46680833)
20. RM Cawthon 2009 Telomere length measurement by a novel monochrome multiplex quantitative PCR method Nucleic Acids Res 37 e21 10.1093/nar/gkn1027 19129229
21. JM Schildkraut E Bastos A Berchuck 1997 Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer J Natl Cancer Inst 89 932 938 10.1093/jnci/89.13.932 1:STN:280: DyaK2szlslensQ%3D%3D 9214672
22. IM Shih RJ Kurman 2004 Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis Am J Pathol 164 1511 1518 1:CAS:528:DC%2BD2cXns1Gqtb0%3D 15111296
23. RJ Kurman I Shih 2008 Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications Int J Gynecol Pathol 27 151 160 18317228
24. A Aviv W Chen JP Gardner, et al. 2009 Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study Am J Epidemiol 169 323 329 10.1093/aje/kwn338 19056834
25. BM Unryn D Hao S Gluck KT Riabowol 2006 Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer Clin Cancer Res 12 6345 6350 10.1158/1078-0432.CCR-06-0486 1:CAS:528:DC%2BD28XhtFKitLfJ 17085644 (Pubitemid 44799703)
26. L Fern M Pallis CG Ian, et al. 2004 Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS Br J Haematol 126 63 71 10.1111/j.1365-2141.2004.05006.x 1:CAS:528:DC%2BD2cXmtl2rt7o%3D 15198733 (Pubitemid 38859483)